Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MD › GREENBELT › THE RETINA GROUP OF WASHINGTON, PLLC

THE RETINA GROUP OF WASHINGTON, PLLC

NPI: 1225001654 · GREENBELT, MD 20770 · Optometrist · NPI assigned 02/08/2006

$19.61M
Total Medicaid Paid
369,283
Total Claims
297,517
Beneficiaries
33
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMADREPERLA, STEVEN (PRESIDENT AND CEO)
NPI Enumeration Date02/08/2006

Related Entities

Other providers sharing the same authorized official: MADREPERLA, STEVEN

ProviderCityStateTotal Paid
ASSOCIATED RETINAL CONSULTANTS LLC VAUXHALL NJ $25.19M
SPOKANE EYE CLINIC PS SPOKANE WA $8.00M
LAKEVIEW SURGERY CENTER LLC BOWIE MD $43K
SEIDENBERG PROTZKO SURGERY CENTER LLC ABERDEEN MD $13K
SPOKANE EYE CLINIC PS SPOKANE WA $3K
ASSOCIATED RETINAL CONSULTANTS, LLC LINWOOD NJ $26.00
FRIENDSHIP AMBULATORY SURGERY CENTER, LLC CHEVY CHASE MD $0.00
THE RETINA GROUP OF WASHINGTON, PLLC ROCKVILLE MD $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 31,948 $511K
2019 45,797 $853K
2020 39,725 $1.33M
2021 56,248 $2.38M
2022 72,779 $4.40M
2023 71,207 $5.78M
2024 51,579 $4.35M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
J0178 Injection, aflibercept, 1 mg 15,254 12,226 $10.45M
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 77,410 64,093 $2.65M
92134 106,803 88,950 $1.73M
67028 Intravitreal injection of a pharmacologic agent 37,853 30,312 $1.18M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 18,081 15,228 $1.07M
J2778 Injection, ranibizumab, 0.1 mg 1,880 1,504 $482K
92202 55,977 47,688 $469K
J0177 Injection, aflibercept hd, 1 mg 485 474 $343K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 4,635 4,121 $317K
J2777 Injection, faricimab-svoa, 0.1 mg 295 270 $149K
J3590 Unclassified biologics 202 191 $138K
92201 7,474 6,386 $122K
J9035 Injection, bevacizumab, 10 mg 3,930 2,973 $115K
92250 4,223 3,642 $101K
92235 2,893 2,509 $83K
J7999 Compounded drug, not otherwise classified 1,259 1,037 $78K
92226 25,222 12,177 $60K
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg 58 57 $22K
67228 79 49 $12K
92225 2,457 1,211 $12K
76512 794 613 $9K
92133 455 381 $8K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 339 301 $7K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 214 197 $6K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 335 285 $2K
92287 68 65 $2K
92083 146 144 $1K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 28 26 $1K
92015 Determination of refractive state 143 117 $677.57
92020 14 14 $264.65
92136 27 26 $144.73
99426 208 208 $0.00
99427 42 42 $0.00